@michael-li.bsky.social
Transplant hepatologist and researcher at the University of California, San Francisco studying liver cancer and autoimmune liver disease. Harvard TH Chan, Brigham and Women’s, and Mount Sinai alum. #LiverSky
For anyone attending #NCCN2025 in Orlando, I'm excited to be speaking during the immune checkpoint inhibitor toxicities session at 1 pm on Friday 3/28. Looking forward to talking about immune-mediated hepatitis with an oncology audience!
@ucsfcancer.bsky.social #LiverSky
When your doctor asks, "How much do you drink?" your answer might not tell the full story. UCSF researchers found that a blood test is more reliable at detecting liver risks early. tiny.ucsf.edu/gwWF23
31.01.2025 21:25 — 👍 0 🔁 1 💬 0 📌 0
And now NIH study sections are being canceled.
www.science.org/content/arti...
Was great to finally meet you in person after virtually collaborating across the Atlantic!
09.12.2024 03:50 — 👍 1 🔁 0 💬 1 📌 0
@bloompringle.bsky.social trying to get the entire AASLD-EASL Masterclass to switch over to Bluesky! #Liversky
08.12.2024 15:13 — 👍 16 🔁 0 💬 0 📌 0
Check out this Poster of Distinction by superstar UCSF intern and future hepatologist Isaac Benque on his work performing proteome-wide autoantibody discovery in PBC using phage immune precipitation sequencing! Really interesting novel diagnostic and prognostic hits.
#Liversky #TLM
This is great! Would love to be added on the next update.
18.11.2024 17:01 — 👍 0 🔁 0 💬 0 📌 0
Great talks at #TLM this morning by Laura Kulik and Parissa Tabrizian about immunotherapy as part of downstaging strategies to liver transplantation or resection! Was nice to see our paper in JHep up on the screen, check it out here: www.journal-of-hepatology.eu/article/S016...
#Liversky
Come join me and Allison Kwong to discuss clinically relevant aspects of surgery for HCC in Ballroom6D at 8 am at #TLM24
• How to downstage
• Optimizing patient for surgery
• Novel surgical techniques
• Weighing resection vs transplant
• LT allocation for HCC
#Liversky
